Prescription drug · NDA
Latisse (Bimatoprost) NDC 0023-3616
Bimatoprost .3 mg/mL · Solution/ drops · Ophthalmic · Allergan, Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0023-3616-05 | 0002336160500023361605 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-05) / 5 mL in 1 BOTTLE, DROPPERMarketed from Jan 26, 2009 | |
| 0023-3616-70 | 0002336167000023361670 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-70) / 3 mL in 1 BOTTLE, DROPPERMarketed from Jan 26, 2009 | |
| 0023-3616-71 | 0002336167100023361671 | 1 BOTTLE, DROPPER in 1 CARTON (0023-3616-71) / 3 mL in 1 BOTTLE, DROPPERMarketed from Jan 26, 2009 · Sample package |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Latisse
- Generic name (nonproprietary)
- bimatoprost
- Active ingredients
- Bimatoprost — .3 mg/mL
- Dosage form
- Solution/ drops
- Route
- Ophthalmic
- Labeler
- Allergan, Inc.NDC labeler code 0023
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 022369
- Marketing start
- Listing expires
- Other FDA classes
- Prostaglandins (Chemical structure)
- Identifiers
- Product ID 0023-3616_f3f30669-e9b1-406b-b6fc-30c520f8ffb3SPL ID f3f30669-e9b1-406b-b6fc-30c520f8ffb3SPL set ID 34f83d9d-2c64-463e-8a90-9a460fedfeadRxCUI 1041495, 1041497UNII QXS94885MZ
- Pharmacologic class
- Prostaglandin Analog
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400023361605followed by a unit qualifier and the quantityPackage 00023-3616-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
LATISSE ® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. LATISSE ® is a prostaglandin analog, indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. ( 1 )
Excerpt only. Read the full label for complete information.
About NDC 0023-3616
- What is NDC 0023-3616?
- 0023-3616 is the product NDC for Latisse (bimatoprost), Bimatoprost .3 mg/mL solution/ drops, listed with the FDA by Allergan, Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Latisse (Bimatoprost).
- What is the active ingredient?
- Bimatoprost.
- Who is the labeler?
- Allergan, Inc., NDC labeler code 0023. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Latisse?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.